Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-β1 against NMDA-induced necrosis

Molecular and Cellular Neuroscience

Volumn 21, Issue 4, 2002, Pages 634-644

  Docagne, Fabian ^a,c   Nicole, Olivier ^a   Gabriel, Cecilia ^a   Fernández Monreal, Mónica ^a   Lesné, Sylvain ^a   Ali, Carine ^a   Plawinski, Laurent ^a   Carmeliet, Peter ^b   MacKenzie, Eric T ^a   Buisson, Alain ^a   Vivien, Denis ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Calcium; Excitotoxicity; NMDA; PAI 1; Smad; t PA; TGF

Indexed keywords

ISOPROTEIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMAD PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALIA;

EID: 0036944699     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2002.1206     Document Type: Article

References (30)

1. Boyd, F. T., and Massague, J. (1989). Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor J. Biol. Chem. 264: 2272-2278.
2. Buisson, A., Nicole, O., Docagne, F., Sartelet, H., MacKenzie, E. T., and Vivien, D. (1998). Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor-β1. FASEB J. 12: 1683-1691.
3. Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., and Mulligan, R. C. (1993). Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J. Clin. Invest. 92: 2746-2755.
4. Choi, D. W. (1992). Excitotoxic cell death J. Neurobiol. 23: 1261-1276.
5. Cinelli, P., Madani, R., Tsuzuki, N., Vallet, P., Arras, M., Zhao, C. N., Osterwalder, T., Rulicke, T., and Sonderegger, P. (2001). Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol. Cell. Neurosci. 18: 443-457.
6. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., and Gauthier, J. M. (1998). Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17: 3091-3100.
7. Docagne, F., Nicole, O., Marti, H. H., MacKenzie, E. T., Buisson, A., and Vivien, D. (1999). Transforming growth factor-β1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB J. 13: 1315-1324.
8. Fiumelli, H., Jabaudon, D., Magistretti, P. J., and Martin, J. L. (1999). BDNF stimulates expression, activity and release of tissue-type plasminogen activator in mouse cortical neurons. Eur. J. Neurosci. 11: 1639-1646.
9. Flanders, K. C., Lippa, C. F., Smith, T. W., Pollen, D. A., and Sporn, M. B. (1995). Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 45: 1561-1569.
10. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-3 signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
11. Henrich-Noack, P., Prehn, J. H., and Krieglstein, J. (1996). TGF-31 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 27: 1609-1614.
12. Koh, J. Y., and Choi, D. W. (1987). Quantitative determination of glutamate-mediated cortical neuronal injury in cell culture by lactate dehydrognase efflux assay J. Neurosci. Methods 20: 83-90.
13. Krupinski, J., Kumar, P., Kumar, S., and Kaluza, J. (1996). Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke 27: 852-857.
14. Mogi, M., Harada, M., Kondo, T., Narabayashi, H., Riederer, P., and Nagatsu, T. (1995). Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci. Lett. 193(2): 129-132.
15. Nagai, N., De Mol, M., Lijnen, H. R., Carmeliet, P., and Collen, D. (1999). Role of plasminogen system components in focal cerebral ischemic infarction: A gene targeting and gene transfer study in mice. Circulation 99: 2440-2444.
16. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16: 5353-5362.
17. Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie, E. T., Vivien, D., and Buisson, A. (2001). The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 7: 59-64.
18. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
19. Prehn, J. H., Backhauss, C., and Krieglstein, J. (1993). Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 3: 521-525.
20. Rogister, B., Leprince, P., Delree, P., Van Damme, J., Billiau, A., and Moonen, G. (1990). Enhanced release of plasminogen activator inhibitor(s) but not of plasminogen activators by cultured rat glial cells treated with interleukin-1. Glia 3: 252-357.
21. Rogister, B., Leprince, P., Pettmann, B., Labourdette, G., Sensenbrenner, M., and Moonen, G. (1988). Brain basic fibroblast growth factor stimulates the release of plasminogen activators by newborn rat cultured astroglial cells. Neurosci. Lett. 91: 321-326.
22. Rose, K., Goldberg, M. P., and Choi, D. W. (1993). Cytotoxicity in murine cortical cell culture. In In Vitro Biological Methods (C. A. Tyson and J. M. Frazier, Eds.), pp. 46-60. Academic press, San Diego.
23. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333: 1581-1587.
24. Treichel, J. A., Reddington, M., and Kreutzberg, G. W. (1998). Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-β1 in cultured rat astrocytes. J. Neurochem. 71: 1944-1952.
25. Tsirka, S. E. (1997). Clinical implications of the involvement of tPA in neuronal cell death. J. Mol. Med. 75: 341-347.
26. Tsirka, S. E., Gualandris, A., Amaral, D. G., and Strickland, S. (1995). Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377: 340-344.
27. Tsirka, S. E., Rogove, A. D., Bugge, T. H., Degen, J. L., and Strickland, S. (1997). An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17: 543-552.
28. Vivien, D., Attisano, L., Wrana, J. L., and Massague, J. (1995). Signaling activity of homologous and heterologous transforming growth factor-β receptor kinase complexes. J. Biol. Chem. 270: 7134-7141.
29. Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., and Lipton, S. A. (1998). Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4: 228-231.
30. Westerhausen, D. R., Jr., Hopkins, W. E., and Billadello, J. J. (1991). Multiple transforming growth factor-β-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells. J. Biol. Chem. 266: 1092-1100.